Combined CAR-T Congress Europe

Combined CAR-T Congress Europe gathers thought leaders from biotech, big pharma, academia and the wider service community to address the challenges and opportunities of CAR-T therapies – including CAR-T, CAR-Tregs and combined therapies - that are critical to furthering the development of viable T-cell therapies.

Exploring ground-breaking developments in this fast growing field, the event will provide the opportunity to collaborate to create a commercially viable, effective and safe therapy.  

Key session topics include:

• Advancements in CAR-T manufacturing and automation
• A combined approach to cell therapy
• Results from unpublished human and clinical studies
• Commercialisation of CAR-T therapies
• Improving the safety of CAR-T through safety switches
• Exploring the tumour microenvironment for therapy targets and improvements
• The potential of CAR-Tregs in autoimmunity

Join us for a rare opportunity to hear first-hand from those with case studies on real patients and insight on solid tumours. Get involved today.